ClinicalTrialsFinder

High-risk Non-muscle Invasive Bladder Cancer Clinical Trials in Cincinnati, Ohio

1 recruitingCincinnati, Ohio

Showing 1–1 of 1 trials

Recruiting
Phase 2

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

High-risk Non-muscle Invasive Bladder Cancer
CG Oncology, Inc.325 enrolled65 locationsNCT06567743